Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Resolution of diabetic papillopathy after a single intravitreal injection of ranibizumab.
Willerslev A, Munch IC, Larsen M.
Acta Ophthalmol. 2012 Jan 23. doi: 10.1111/j.1755-3768.2011.02282.x. [Epub ahead of print] No abstract available.
Related citations
The prevalence of cataract in a population with and without type 2 diabetes mellitus.
Olafsdottir E, Andersson DK, Stefánsson E.
Acta Ophthalmol. 2012 Jun;90(4):334-40. doi: 10.1111/j.1755-3768.2011.02326.x. Epub 2011 Dec 16.
Optos-guided pattern scan laser (Pascal)-targeted retinal photocoagulation in proliferative diabetic retinopathy.
Muqit MM, Marcellino GR, Henson DB, Young LB, Patton N, Charles SJ, Turner GS, Stanga PE.
Acta Ophthalmol. 2011 Dec 16. doi: 10.1111/j.1755-3768.2011.02307.x. [Epub ahead of print]
Nine-month results of intravitreal bevacizumab versus triamcinolone for the treatment of diffuse diabetic macular oedema: a retrospective analysis.
Kook PE, Maier M, Schuster T, Feucht N, Lohmann CP.
Acta Ophthalmol. 2011 Dec;89(8):769-73. doi: 10.1111/j.1755-3768.2009.01823.x.
Prevalence of diabetic retinopathy in Norway: report from a screening study.
Kilstad HN, Sjølie AK, Gøransson L, Hapnes R, Henschien HJ, Alsbirk KE, Fossen K, Bertelsen G, Holstad G, Bergrem H.
Acta Ophthalmol. 2011 Sep 28. doi: 10.1111/j.1755-3768.2011.02160.x. [Epub ahead of print]
Resveratrol blocks diabetes-induced early vascular lesions and vascular endothelial growth factor induction in mouse retinas.
Kim YH, Kim YS, Roh GS, Choi WS, Cho GJ.
Acta Ophthalmol. 2012 Feb;90(1):e31-7. doi: 10.1111/j.1755-3768.2011.02243.x. Epub 2011 Sep 13.
The post-illumination pupil response of melanopsin-expressing intrinsically photosensitive retinal ganglion cells in diabetes.
Feigl B, Zele AJ, Fader SM, Howes AN, Hughes CE, Jones KA, Jones R.
Acta Ophthalmol. 2012 May;90(3):e230-4. doi: 10.1111/j.1755-3768.2011.02226.x. Epub 2011 Aug 23.
Influence of cataract surgery on pupil size in patients with diabetes mellitus.
Totsuka K, Kato S, Shigeeda T, Honbo M, Kataoka Y, Nakahara M, Miyata K.
Acta Ophthalmol. 2012 May;90(3):e237-9. doi: 10.1111/j.1755-3768.2011.02204.x. Epub 2011 Jul 29. No abstract available.
Topical treatment for 1 week with latanoprost but not diclofenac reduces the diameter of dilated retinal arterioles in patients with type 1 diabetes mellitus and mild retinopathy.
Tilma KK, Bek T.
Acta Ophthalmol. 2011 Jul 5. doi: 10.1111/j.1755-3768.2011.02185.x. [Epub ahead of print]
Panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab for high-risk proliferative diabetic retinopathy.
Filho JA, Messias A, Almeida FP, Ribeiro JA, Costa RA, Scott IU, Jorge R.
Acta Ophthalmol. 2011 Nov;89(7):e567-72. doi: 10.1111/j.1755-3768.2011.02184.x. Epub 2011 Jul 5.
Awareness of diabetic retinopathy among diabetic patients in Nepal.
Thapa R, Paudyal G, Maharjan N, Bernstein PS.
Acta Ophthalmol. 2012 May;90(3):e242. doi: 10.1111/j.1755-3768.2011.02163.x. Epub 2011 Jun 8. No abstract available.
Monitoring diabetic retinopathy in pregnancy: meeting the NICE guidelines.
De Silva SR, Riaz Y, Watson SL.
Acta Ophthalmol. 2012 May;90(3):e243-4. doi: 10.1111/j.1755-3768.2011.02158.x. Epub 2011 Apr 21. No abstract available.
Decreased prothrombin time after intravitreal bevacizumab in the early period in patients with proliferative diabetic retinopathy.
Qian J, Jiang YR.
Acta Ophthalmol. 2011 Jun;89(4):e332-5. doi: 10.1111/j.1755-3768.2011.02151.x. Epub 2011 Apr 6.
Microvascular retinopathy in subjects without diabetes: the Inter99 Eye Study.
Munch IC, Kessel L, Borch-Johnsen K, Glümer C, Lund-Andersen H, Larsen M.
Acta Ophthalmol. 2011 Apr 6. doi: 10.1111/j.1755-3768.2011.2148.x. [Epub ahead of print]
Comparison of a single intravitreal injection of bevacizumab versus triamcinolone acetonide as primary treatment for diffuse diabetic macular oedema.
Penha FM, Maia M, Cardillo JA, Fernando Arevalo J, Wu L, Rodriguez FJ, Berrocal MH, Farah ME; from The Pan-American Collaborative Retina Study Group (PACORES).
Acta Ophthalmol. 2011 Apr 6. doi: 10.1111/j.1755-3768.2010.02098.x. [Epub ahead of print] No abstract available.
Risk factors for diabetic retinopathy in a rural Chinese population with type 2 diabetes: the Handan Eye Study.
Wang FH, Liang YB, Peng XY, Wang JJ, Zhang F, Wei WB, Sun LP, Friedman DS, Wang NL, Wong TY; Handan Eye Study Group.
Acta Ophthalmol. 2011 Jun;89(4):e336-43. doi: 10.1111/j.1755-3768.2010.02062.x. Epub 2011 Mar 4.
Intraocular expression of thymosin β4 in proliferative diabetic retinopathy.
Wang JY, Lu Q, Tao Y, Jiang YR, Jonas JB.
Acta Ophthalmol. 2011 Aug;89(5):e396-403. doi: 10.1111/j.1755-3768.2011.02114.x. Epub 2011 Feb 18.
Treatment of proliferative diabetic retinopathy with anti-VEGF agents.
Salam A, Mathew R, Sivaprasad S.
Acta Ophthalmol. 2011 Aug;89(5):405-11. doi: 10.1111/j.1755-3768.2010.02079.x. Epub 2011 Feb 5. Review.
Repeated intravitreal bevacizumab (Avastin(®)) treatment of persistent new vessels in proliferative diabetic retinopathy after complete panretinal photocoagulation.
Schmidinger G, Maar N, Bolz M, Scholda C, Schmidt-Erfurth U.
Acta Ophthalmol. 2011 Feb;89(1):76-81. doi: 10.1111/j.1755-3768.2009.01622.x.
Eye complications and markers of morbidity and mortality in long-term type 1 diabetes.
Grauslund J.
Acta Ophthalmol. 2011 Feb;89 Thesis 1:1-19. doi: 10.1111/j.1755-3768.2010.02105.x.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on